Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lymdiaral Injektopas pilot study in PEFS and chronic venous-lymphatic insufficiency
2009-014816-37Phase 4Completed
- Sponsor
- Named
- Start
- Nov 2009
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lymdiaral in chronic venous lymphatic insufficiency (CVLI) and cellulite, sponsored by Named. Primary endpoint: Tolerability of Lymdiaral Injektopas. Started Nov 2009; status: completed.
02
Drugs
Lymdiaral
03
Conditions
chronic venous lymphatic insufficiency (CVLI)cellulite
Beyond the preview
Go deeper on 2009-014816-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014816-37.